DK0963987T3 - Spiro(piperidin-4,1'-pyrrolo(3,4-c)pyrrol) - Google Patents
Spiro(piperidin-4,1'-pyrrolo(3,4-c)pyrrol)Info
- Publication number
- DK0963987T3 DK0963987T3 DK99110944T DK99110944T DK0963987T3 DK 0963987 T3 DK0963987 T3 DK 0963987T3 DK 99110944 T DK99110944 T DK 99110944T DK 99110944 T DK99110944 T DK 99110944T DK 0963987 T3 DK0963987 T3 DK 0963987T3
- Authority
- DK
- Denmark
- Prior art keywords
- pyrrolo
- spiro
- pyrrole
- piperidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/20—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Addiction (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98110803 | 1998-06-12 | ||
EP98124119 | 1998-12-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0963987T3 true DK0963987T3 (da) | 2002-12-30 |
Family
ID=26149342
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK99110944T DK0963987T3 (da) | 1998-06-12 | 1999-06-07 | Spiro(piperidin-4,1'-pyrrolo(3,4-c)pyrrol) |
Country Status (27)
Country | Link |
---|---|
US (1) | US6075034A (hr) |
EP (1) | EP0963987B1 (hr) |
JP (1) | JP3308507B2 (hr) |
KR (1) | KR100346607B1 (hr) |
AR (1) | AR018650A1 (hr) |
AT (1) | ATE222908T1 (hr) |
AU (1) | AU749995B2 (hr) |
BR (1) | BR9902245A (hr) |
CA (1) | CA2274204C (hr) |
CO (1) | CO5060459A1 (hr) |
DE (1) | DE69902606T2 (hr) |
DK (1) | DK0963987T3 (hr) |
ES (1) | ES2181336T3 (hr) |
HR (1) | HRP990189A2 (hr) |
HU (1) | HUP9901909A3 (hr) |
ID (1) | ID23283A (hr) |
IL (1) | IL130376A0 (hr) |
MA (1) | MA26643A1 (hr) |
NO (1) | NO312069B1 (hr) |
NZ (1) | NZ336186A (hr) |
PE (1) | PE20000549A1 (hr) |
PL (1) | PL333694A1 (hr) |
PT (1) | PT963987E (hr) |
SG (1) | SG76623A1 (hr) |
TR (1) | TR199901304A2 (hr) |
TW (1) | TW523516B (hr) |
YU (1) | YU26599A (hr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002224038B2 (en) | 2000-11-15 | 2006-03-09 | Banyu Pharmaceutical Co., Ltd. | Benzimidazole derivatives |
JP2005502619A (ja) * | 2001-07-02 | 2005-01-27 | オメロス コーポレイション | オピオイドレセプター様レセプター1アゴニストと交替でオピオイドレセプターアゴニストを投与することを含む、痛覚脱失を生成するための方法 |
US20030040479A1 (en) * | 2001-07-02 | 2003-02-27 | Omeros Corporation | Rotational intrathecal analgesia method and device |
JP2005289816A (ja) | 2002-05-14 | 2005-10-20 | Banyu Pharmaceut Co Ltd | ベンズイミダゾール誘導体 |
US20080287478A1 (en) * | 2003-05-23 | 2008-11-20 | Lars Bo Laurenborg Hansen | Nociceptin Analogues and Uses Thereof |
US20050228023A1 (en) * | 2003-12-19 | 2005-10-13 | Sri International | Agonist and antagonist ligands of the nociceptin receptor |
JP4446978B2 (ja) * | 2006-04-28 | 2010-04-07 | トヨタ自動車株式会社 | 車両用駆動力制御装置 |
AU2008219980B2 (en) * | 2007-03-01 | 2012-01-12 | Mitsubishi Tanabe Pharma Corporation | Benzimidazole compound and pharmaceutical use thereof |
KR101561666B1 (ko) | 2014-08-12 | 2015-10-20 | 최인석 | 골프 퍼팅 교정장치 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5534520A (en) * | 1990-04-10 | 1996-07-09 | Fisher; Abraham | Spiro compounds containing five-membered rings |
CA2226058C (en) * | 1997-01-30 | 2008-01-29 | F. Hoffmann-La Roche Ag | 8-substituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives |
-
1999
- 1999-06-07 EP EP99110944A patent/EP0963987B1/en not_active Expired - Lifetime
- 1999-06-07 AT AT99110944T patent/ATE222908T1/de active
- 1999-06-07 DE DE69902606T patent/DE69902606T2/de not_active Expired - Lifetime
- 1999-06-07 ES ES99110944T patent/ES2181336T3/es not_active Expired - Lifetime
- 1999-06-07 DK DK99110944T patent/DK0963987T3/da active
- 1999-06-07 PT PT99110944T patent/PT963987E/pt unknown
- 1999-06-08 PE PE1999000485A patent/PE20000549A1/es not_active Application Discontinuation
- 1999-06-09 NZ NZ336186A patent/NZ336186A/xx unknown
- 1999-06-09 CO CO99036175A patent/CO5060459A1/es unknown
- 1999-06-09 IL IL13037699A patent/IL130376A0/xx unknown
- 1999-06-09 SG SG1999002779A patent/SG76623A1/en unknown
- 1999-06-09 HU HU9901909A patent/HUP9901909A3/hu unknown
- 1999-06-09 CA CA002274204A patent/CA2274204C/en not_active Expired - Fee Related
- 1999-06-10 MA MA25615A patent/MA26643A1/fr unknown
- 1999-06-10 JP JP16397599A patent/JP3308507B2/ja not_active Expired - Fee Related
- 1999-06-10 TR TR1999/01304A patent/TR199901304A2/xx unknown
- 1999-06-10 YU YU26599A patent/YU26599A/sh unknown
- 1999-06-10 AR ARP990102765A patent/AR018650A1/es active IP Right Grant
- 1999-06-10 KR KR1019990021570A patent/KR100346607B1/ko not_active IP Right Cessation
- 1999-06-11 HR HR98124119.3A patent/HRP990189A2/hr not_active Application Discontinuation
- 1999-06-11 AU AU35003/99A patent/AU749995B2/en not_active Ceased
- 1999-06-11 BR BR9902245A patent/BR9902245A/pt not_active Application Discontinuation
- 1999-06-11 PL PL99333694A patent/PL333694A1/xx unknown
- 1999-06-11 US US09/330,857 patent/US6075034A/en not_active Expired - Fee Related
- 1999-06-11 NO NO19992872A patent/NO312069B1/no unknown
- 1999-06-14 ID IDP990577A patent/ID23283A/id unknown
- 1999-06-21 TW TW088110336A patent/TW523516B/zh active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE59409351D1 (de) | Pyrrolo[3,4-c]pyrrole | |
HUP9900575A3 (en) | Pyrazolopyrimidines as crf receptor antagonists | |
DE69905652T2 (de) | Direkte Herstellung von Pyrrolo-(3,4-c)pyrrolpigmenten | |
DK0837860T3 (da) | Tricykliske 5,6-dihydro-9H-pyrazolo[3,4-c]-1,2,4-triazolo-[4,3-alfa]pyridiner | |
DK0963987T3 (da) | Spiro(piperidin-4,1'-pyrrolo(3,4-c)pyrrol) | |
DK0970957T3 (da) | Diaza-spiro[3.5]nonan-derivativer | |
ZA972829B (en) | Novel pyrimido [1,2-a]indoles. | |
ZA993853B (en) | Spiro[piperidine-4,1'-pyrolo(3,4-C)pyrrole]. | |
DE59606457D1 (de) | Monophasige feste Lösungen mit asymmetrischen Pyrrolo-[4,3-c]-pyrrolen als Wirten | |
ZA974538B (en) | Novel pyrrole derivatives. | |
PL356668A1 (en) | Novel substituted pyrazolo[4,3-e | |
DE59510186D1 (de) | Cyaniminogruppen enthaltende Pyrrolo(3,4-c)pyrrole | |
EP0424315A3 (en) | Tetracyclic pyrrole lactam derivatives | |
DE59500031D1 (de) | Aminoxidgruppen enthaltende Pyrrolo[3,4-c]pyrrole als Photorezeptoren | |
ZA964649B (en) | Tricyclic 5,6-dihydro-9H-pyrazolo[3,4c]-1,2,4-triazolo[4,3a]pyridines. | |
SI0880523T1 (sl) | Pirazolopirimidini kot crf receptorski antagonisti | |
PL325562A1 (en) | Novel derivative of pyrrole[3,4-c]pyridine or 3,4-pyridinodicarboxyimide |